收藏切换
Analysis of costs coverage for specialized drugs for patients with Gaucher disease in Shanghai
收藏切换
Qi KANG1, Dingguo LI2, 3, Hao YANG4, Chunlin JIN1, *
World Clinical Drug | 2022, 43(2) : 135 - 139
Less
收藏切换
World Clinical Drug | 2022, 43(2): 135-139
• Topic •
Analysis of costs coverage for specialized drugs for patients with Gaucher disease in Shanghai
Full
Qi KANG1, Dingguo LI2, 3, Hao YANG4, Chunlin JIN1, *
Affiliations
  • 1.Shanghai Health Development Research Center, Shanghai 200040, China
  • 2.Shanghai Foundation for the Prevention and Treatment of Rare Diseases, Shanghai 200040, China
  • 3.Xinhua Hospital of Shanghai Jiaotong University School of Medicine, Shanghai 200092, China
  • 4.School of Economics and Management, Jiangxi University of TCM Nanchang, Nanchang 330004, Jiangxi Province, China
Published: 2022-02-10 doi: 10.13683/j.wph.2022.02.005
Outline
收藏切换

For Gaucher Disease, a rare disease, which requires high-value medication for treatment, Shanghai has established a multi-tiered system consisting of the Basic Medical Insurance (BMI), the Shanghai Rare Disease Prevention and Control Foundation Lysosomal Storage Disease Special Aid Fund (SAF), and the Shanghai Primary and Secondary School Students, Infants and Children Hospitalization Medical Mutual Fund (CHMF) for insuring Gaucher Disease. This security system was the leading one in China at that time, and patients with Gaucher Disease in Shanghai could really have access to medicine. In order to understand the guarantee of high-value specific drugs for Gaucher Disease patients, this paper analyzed the cost-sharing situation of Gaucher Disease from 2018 to 2020, and found that the total cost for six patients was 36.35 millions Chinese Yuan (CNH), an average of 2.02 millions CNH for per person per year. Among the costs, the proportions of BMI, SAF and individual out-of-pocket rate were 79.02%, 16.28% and 4.70%, respectively. From the Shanghai coverage experience, it can be found that high-value drugs for rare diseases are very expensive, a high level of coverage is needed to ensure that patients actually have access to the drugs, and this often requires multiple parties to work together to establish a coverage mechanism.

Gaucher disease  /  specialized drugs  /  pharmacoeconomics
康琦, 李定国, 杨浩, 金春林. 上海戈谢病患者特效药费用保障分析. 世界临床药物, 2022 , 43 (2) : 135 -139 . DOI: 10.13683/j.wph.2022.02.005
Qi KANG, Dingguo LI, Hao YANG, Chunlin JIN. Analysis of costs coverage for specialized drugs for patients with Gaucher disease in Shanghai[J]. World Clinical Drug, 2022 , 43 (2) : 135 -139 . DOI: 10.13683/j.wph.2022.02.005
Year 2022 volume 43 Issue 2
14
4
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.02.005
  • Receive Date:2021-12-10
  • Online Date:2026-11-19
  • Published:2022-02-10
Article Data
Affiliations
History
  • Received:2021-12-10
Affiliations
    1.Shanghai Health Development Research Center, Shanghai 200040, China
    2.Shanghai Foundation for the Prevention and Treatment of Rare Diseases, Shanghai 200040, China
    3.Xinhua Hospital of Shanghai Jiaotong University School of Medicine, Shanghai 200092, China
    4.School of Economics and Management, Jiangxi University of TCM Nanchang, Nanchang 330004, Jiangxi Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.02.005
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT